H

Humacyte
D

HUMA

3.55000
USD
-0.20
(-5.33%)
مغلق
حجم التداول
42,633
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
456,773,118
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Humacyte

القطاع: Healthcare
الصناعة: Biotechnology
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.